ArticleBioData mining2026
BPX-Net: biomarker-preserved explainable networks for disease diagnosis and prognosis.
Article in BioData mining, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Precise diagnosis of complex diseases increasingly depends on the integration of multimodal data. However, the high dimensionality of such data makes it difficult for traditional modeling methods to efficiently identify biomarkers, while deep learning approaches, despite their strong predictive power, often lack interpretability. Here, we introduce BPX-Net, a generalizable deep learning framework that learns compact multimodal representations through a biomarker-preserving dropout mechanism, where dropout probabilities are modulated by feature importance scores self-learned from a built-in interpretability module and, when available, further informed by clinical priors. This design enables BPX-Net to make robust predictions during inference by selectively attending to a sparse set of disease-informative predictors, making it insensitive to missing values in less relevant or redundant variables. Across multi-center cohorts covering diverse clinical tasks (disease diagnosis, prognosis, treatment response prediction, and risk stratification), BPX-Net yields substantial performance gains, e.g. achieving an average AUC of 85.43% across four tasks, outperforming baselines by 4% to 20% in the presence of missing data. More importantly, it identifies predictors aligned with established clinical knowledge. Cross-hospital validation further confirms the robustness and clinical relevance of these predictors. Collectively, BPX-Net offers a clinically grounded deep learning framework for multimodal analysis, intrinsically robust to data incompleteness and equipped with built-in interpretability, thereby eliminating reliance on computationally intensive post-hoc tools such as SHAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.